Summary

● The company usually posts poor financials for mid or long term investments.

● For a short-term investment strategy, the company has poor fundamentals.

Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at USD 7.03.

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● Low profitability weakens the company.

● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The company's earnings releases usually do not meet expectations.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 235.58 times its estimated earnings per share for the ongoing year.

● The company is not the most generous with respect to shareholders' compensation.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Most analysts recommend that the stock should be sold or reduced.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.